NASDAQ:ALDR
Delisted

Alder BioPharmaceuticals Stock Price (Quote)

$18.88
+0 (+0%)
At Close: Apr 15, 2020

Range Low Price High Price Comment
30 days $18.88 $18.88 Wednesday, 15th Apr 2020 ALDR stock ended at $18.88. During the day the stock fluctuated 0% from a day low at $18.88 to a day high of $18.88.
90 days $18.88 $18.88
52 weeks $8.39 $19.12

Historical Alder BioPharmaceuticals prices

Date Open High Low Close Volume
Mar 14, 2018 $15.20 $15.40 $14.35 $14.45 609 668
Mar 13, 2018 $14.90 $15.55 $14.85 $15.25 1 353 579
Mar 12, 2018 $15.25 $15.50 $14.80 $14.90 644 204
Mar 09, 2018 $15.20 $15.33 $14.85 $15.20 755 879
Mar 08, 2018 $15.00 $15.30 $14.80 $15.15 950 937
Mar 07, 2018 $14.90 $15.05 $14.63 $14.90 1 561 625
Mar 06, 2018 $14.90 $15.10 $14.50 $14.90 993 786
Mar 05, 2018 $14.40 $15.35 $14.23 $14.95 1 840 364
Mar 02, 2018 $13.80 $14.40 $13.50 $14.35 1 730 518
Mar 01, 2018 $13.90 $14.15 $13.53 $13.85 1 222 569
Feb 28, 2018 $14.25 $14.60 $13.85 $13.90 899 682
Feb 27, 2018 $14.75 $15.00 $13.70 $14.20 2 553 588
Feb 26, 2018 $14.80 $15.15 $14.40 $14.75 894 379
Feb 23, 2018 $14.45 $14.80 $14.33 $14.75 926 912
Feb 22, 2018 $14.75 $14.75 $14.13 $14.30 1 334 819
Feb 21, 2018 $13.80 $14.90 $13.75 $14.55 1 879 671
Feb 20, 2018 $13.75 $14.18 $13.45 $13.85 1 462 855
Feb 16, 2018 $14.10 $14.10 $13.50 $13.55 1 229 385
Feb 15, 2018 $14.35 $14.35 $13.90 $14.05 1 453 333
Feb 14, 2018 $13.10 $14.50 $13.00 $14.35 2 471 676
Feb 13, 2018 $13.20 $13.50 $12.95 $13.30 1 329 011
Feb 12, 2018 $13.30 $13.50 $12.90 $13.30 2 022 630
Feb 09, 2018 $13.40 $13.90 $12.45 $13.25 1 556 136
Feb 08, 2018 $13.90 $14.50 $13.15 $13.25 2 437 499
Feb 07, 2018 $13.65 $14.20 $13.65 $13.90 1 331 410
Click to get the best stock tips daily for free!

About Alder BioPharmaceuticals

Alder BioPharmaceuticals Alder BioPharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes therapeutic antibodies in the United States and Australia. The company’s lead product candidate ALD403, an antibody, which is in Phase II clinical trial to target calcitonin gene-related peptide for the prevention of migraine. It also develops ALD1613, which is in preclinical stage to treat patients with congenital adrenal hyperpla... ALDR Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT